Literature DB >> 35354988

Hepatitis B and the liver cancer endgame.

Kristina Campbell.   

Abstract

Entities:  

Keywords:  Diseases; Medical research; Microbiology; Microbiome

Mesh：

Year:  2022        PMID： 35354988     DOI： 10.1038/d41586-022-00821-0

Source DB:  PubMed          Journal:  Nature        ISSN： 0028-0836            Impact factor:   69.504


× No keyword cloud information.
  6 in total

1.  Gut microbiota dysbiosis in patients with hepatitis B virus-induced chronic liver disease covering chronic hepatitis, liver cirrhosis and hepatocellular carcinoma.

Authors:  Yongbin Zeng; Shanjian Chen; Ya Fu; Wennan Wu; Tianbin Chen; Jing Chen; Bin Yang; Qishui Ou
Journal:  J Viral Hepat       Date:  2019-10-29       Impact factor: 3.728

2.  Comprehensive review of Hepatitis B Virus-associated hepatocellular carcinoma research through text mining and big data analytics.

Authors:  Wai Yeow Lee; Maulana Bachtiar; Cheryl C S Choo; Caroline G Lee
Journal:  Biol Rev Camb Philos Soc       Date:  2018-08-13

3.  Cost-Effectiveness of 1-Time Universal Screening for Chronic Hepatitis B Infection in Adults in the United States.

Authors:  Mehlika Toy; David Hutton; Aaron M Harris; Noele Nelson; Joshua A Salomon; Samuel So
Journal:  Clin Infect Dis       Date:  2022-01-29       Impact factor: 9.079

4.  Gut microbiota impact on the peripheral immune response in non-alcoholic fatty liver disease related hepatocellular carcinoma.

Authors:  Jason Behary; Nadia Amorim; Xiao-Tao Jiang; Anita Raposo; Lan Gong; Emily McGovern; Ragy Ibrahim; Francis Chu; Carlie Stephens; Hazem Jebeili; Vincenzo Fragomeli; Yen Chin Koay; Miriam Jackson; John O'Sullivan; Martin Weltman; Geoffrey McCaughan; Emad El-Omar; Amany Zekry
Journal:  Nat Commun       Date:  2021-01-08       Impact factor: 14.919

5.  Aberrant integration of Hepatitis B virus DNA promotes major restructuring of human hepatocellular carcinoma genome architecture.

Authors:  Jonas Demeulemeester; Paula Otero; Clemency Jolly; Daniel García-Souto; Urtzi Garaigorta; Peter J Campbell; Hidewaki Nakagawa; Peter Van Loo; Eva G Álvarez; Ana Pequeño-Valtierra; Jorge Zamora; Marta Tojo; Javier Temes; Adrian Baez-Ortega; Bernardo Rodriguez-Martin; Ana Oitaben; Alicia L Bruzos; Mónica Martínez-Fernández; Kerstin Haase; Sonia Zumalave; Rosanna Abal; Jorge Rodríguez-Castro; Aitor Rodriguez-Casanova; Angel Diaz-Lagares; Yilong Li; Keiran M Raine; Adam P Butler; Iago Otero; Atsushi Ono; Hiroshi Aikata; Kazuaki Chayama; Masaki Ueno; Shinya Hayami; Hiroki Yamaue; Kazuhiro Maejima; Miguel G Blanco; Xavier Forns; Carmen Rivas; Juan Ruiz-Bañobre; Sofía Pérez-Del-Pulgar; Raúl Torres-Ruiz; Sandra Rodriguez-Perales; Jose M C Tubio
Journal:  Nat Commun       Date:  2021-11-25       Impact factor: 14.919

6.  Alteration in gut microbiota associated with hepatitis B and non-hepatitis virus related hepatocellular carcinoma.

Authors:  Qisha Liu; Fan Li; Yaoyao Zhuang; Jian Xu; Jianwei Wang; Xuhua Mao; Yewei Zhang; Xingyin Liu
Journal:  Gut Pathog       Date:  2019-01-18       Impact factor: 4.181
  6 in total
  1 in total

1.  Risk factors for postoperative portal vein thrombosis in patients with hepatitis B liver cancer and its impact on mortality-a retrospective study.

Authors:  Zhongshan Yu; Yizhi Zhou; Ya Li; Long Xu
Journal:  Transl Cancer Res       Date:  2022-08       Impact factor: 0.496
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.